Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer - Trial NCT06349252
Access comprehensive clinical trial information for NCT06349252 through Pure Global AI's free database. This phase not specified trial is sponsored by Fudan University and is currently Recruiting. The study focuses on Non-small Cell Lung Cancer. Target enrollment is 1263 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Fudan University
Timeline & Enrollment
N/A
Jan 01, 2021
Jan 01, 2025
Primary Outcome
Overall Survival
Summary
The International Association for the Study of Lung Cancer Staging Committee recently
 unveiled the ninth edition of TNM staging system for lung cancer. This study aims to explore
 survival outcomes, stage grouping, and gene mutations in N descriptors of this new
 classification system.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06349252
Non-Device Trial